Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.010 USD UNCHANGED
Streaming Delayed Price Updated: 5:51 AM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amarin Corp Ads

< Previous 1 2
...
83 84 85 86 87 88 89 90 Next >
Drug Makers on the Upswing as FDA Relationships Improve
The Bedford Report Provides Analyst Research on Orexigen Therapeutics & Amarin Corp 
From Marketwired News Releases
Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
From PR Newswire
Retail stocks may stay in late-trading focus
Shares of retailers may stay on late-traders’ radar Monday evening, with the performance of the holiday shopping season still on the minds of many analysts and investors. 
Tags Internet Hardware Market News DJIA
From MarketWatch
Amarin Reports Upbeat Trial Results
Amarin Corp. (Nasdaq: AMRN) reported positive results from a Phase III clinical trial of its very high triglyceride treatment AMR101 sending the stock price soaring $1.93 to $5.48. ... 
From MarketMinute.com Stock News
Amarin, AMAG rally, but drug indexes fall
Amarin Corp. and AMAG Pharmaceuticals shares are rallying in morning trading Monday as the drug sector’s two key indexes fall. 
Tags Analyst Market News Analyst Research/Ratings
From MarketWatch
U.S. stocks slump after Ireland bailout
U.S. stocks fell Monday despite the sealing of a $113 billion Irish bailout as investors were skeptical of its ability to contain the euro-zone debt crisis. 
Tags DJIA Market News DXY
From MarketWatch
Investors Continue To Worry About European Debt
Continued concerns about debt problems in Europe sent the markets tumbling to a sharply lower open with the Dow plunging 113 points to 10,978. Nasdaq dropped 25 points to 2509. 
Tags Market News
From MarketMinute.com Market Updates
Monday’s biggest gaining and declining stocks
Shares of the following companies are making notable moves ahead of the U.S. stock market open on Monday. 
Tags Pharmaceuticals Market News NTSP
From MarketWatch
UPDATE 1-Amarin drug hits goals, shares up 24pct pre market
* High-dose AMR101 cut triglyceride levels by 33 percent 
Tags companyNews
From Reuters: Company News
Amarin drug hits goals, may rival Glaxo's Lovaza
* Amarin brings forward U.S. filing date for drug to 2011 
Tags companyNews
From Reuters: Company News
Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Inc
- Largest controlled therapeutics trial in patients with very high triglycerides 
From PR Newswire
Amarin to Host Conference Call at 8:30 a.m. EST on November 29, 2010, to Discuss Top-Line Results of Phase 3 MARINE Study of AMR101 in Patients with Very High Triglycerides
MARINE Study is Largest Controlled Therapeutic Trial Ever Conducted in Patients with Very High Triglycerides 
From PR Newswire
Amarin Corporation Appoints Kristine Peterson to Board of Directors
From PR Newswire
Amarin to Present at Lazard Capital Markets Annual Healthcare Conference
From PR Newswire
Amarin Reports Third Quarter 2010 Financial Results and Positively Updates Phase 3 Guidance
-Phase 3 milestones moved ahead into 2010 for report of top line results of MARINE trial and completion of ANCHOR trial randomization- 
From PR Newswire
Amarin Corporation Announces Senior Management Changes
-Conference call today at 11:00 AM Eastern Time- 
From PR Newswire
Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
From PR Newswire
Amarin to Present at Oppenheimer & Co. Inc. Annual Healthcare Conference
From PR Newswire
Amarin to Present at NewsMakers in the Biotech Industry Conference
From PR Newswire
Amarin to Present at UBS Life Sciences Conference
From PR Newswire
St. Renatus LLC Planning Phase 3 Trials, Joins SAFE-BioPharma Association
From Business Wire News Releases
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
From PR Newswire
Amarin Reports Q2 2010 Results
-MARINE trial results due early 2011; ANCHOR trial >50% randomized- 
From PR Newswire
Amarin's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization
- Trial Guidance Positively Updated - 
From PR Newswire
Amarin Corporation to Host Investor Conference Call on Tuesday, August 10, 2010
From PR Newswire
Amarin to Present at Canaccord Genuity Global Growth Conference
From PR Newswire
DIA Annual Meeting Highlights End of Paper-Based Systems via SAFE-BioPharma Industry Standard
From Business Wire News Releases
Amarin to Present at Two Upcoming Investor Conferences
From PR Newswire
IPS Research Company is First Clinical Research Investigator Site to Join SAFE-BioPharma Association
From Business Wire News Releases
Amarin to Present at the Rodman & Renshaw Global Investment Conference
From PR Newswire
< Previous 1 2
...
83 84 85 86 87 88 89 90 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.